Experienced commercial leader with a track record of growing revenue across healthcare and distribution markets. Skilled in sales strategy, forecasting, and executive relationship management, with success leading teams, expanding strategic accounts, and delivering measurable growth across medical technology,diagnostics, infusion systems,medication management and diabetes care. Known for translating market insights into stronger commercial performance.
· Led strategic market intelligence initiatives supporting a global business valued at approximately $130M.
· Influenced commercial strategy and investment decisions by analyzing customer insights, competitive intelligence, and market opportunities.
· Developed market-sizing analyses that identified growth opportunities worth $45M-$65M in potential revenue.
· Developed market-sizing analyses identifying growth opportunities of $45M-$65M in potential revenue.
· Delivered executive recommendations that guided product commercialization, portfolio strategy, and market prioritization.
· Partnered with business unit leadership, product management, and regional commercial teams to support strategic planning and growth initiatives.
· Identified strategic growth opportunities expected to generate $25M in incremental revenue.
Key Achievements
· Generated approximately $300M in new business revenue, contributing to 59% year-over-year growth.
· Developed and executed national growth strategies, enhancing market share across retail pharmacy, long-term care, institutional healthcare, and government sectors.
· Negotiated strategic partnerships with healthcare organizations and government agencies resulting in $200M in annual revenue.
· Led pricing and contracting strategies that increased profitability and market penetration while improving customer retention.
· Directed inside sales team of 15, driving retail pharmacy and long-term care growth initiatives.
· Collaborated with federal and provincial stakeholders to accelerate adoption of diagnostic technologies.
· Built a qualified pipeline exceeding $21M while improving close rates by 89%.
Commercial Scope